FR56F - Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne ou vasculaire. - Google Patents

Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne ou vasculaire.

Info

Publication number
FR56F
FR56F FR933624A FR933624A FR56F FR 56 F FR56 F FR 56F FR 933624 A FR933624 A FR 933624A FR 933624 A FR933624 A FR 933624A FR 56 F FR56 F FR 56F
Authority
FR
France
Prior art keywords
spasms
coronary
treatment
new drug
vascular origin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR933624A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to DK395263A priority Critical patent/DK105465C/da
Priority to DK395363A priority patent/DK105587C/da
Priority to DK395463A priority patent/DK105335C/da
Priority to DK395163A priority patent/DK105464C/da
Priority to CH532166A priority patent/CH434251A/fr
Priority to CH1037763A priority patent/CH427790A/fr
Priority to CH1037863A priority patent/CH433283A/fr
Priority to ES290991A priority patent/ES290991A1/es
Priority to CH1037963A priority patent/CH421958A/fr
Priority to CH532066A priority patent/CH429721A/fr
Priority to CH1037663A priority patent/CH427789A/fr
Priority to GB3393563A priority patent/GB1025905A/en
Priority to FR976906A priority patent/FR121F/fr
Application granted granted Critical
Publication of FR56F publication Critical patent/FR56F/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR933624A 1962-08-27 1963-05-03 Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne ou vasculaire. Expired FR56F (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
DK395363A DK105587C (da) 1962-08-27 1963-08-19 Fremgangsmåde til fremstilling af 3,11-dioxo-20-alkyl-20-amino-Δ<4>-pregnenderivater eller salte heraf.
DK395463A DK105335C (da) 1962-08-27 1963-08-19 Fremgangsmåde til fremstilling af 3β-hydroxy- eller 3β-acyloxy-20-alkyl-20-amino-5α-pregnanderivater eller salte heraf.
DK395163A DK105464C (da) 1962-08-27 1963-08-19 Fremgangsmåde til fremstilling af 20-alkyl-20-aminosteroider eller salte af disse forbindelser.
DK395263A DK105465C (da) 1962-08-27 1963-08-19 Fremgangsmåde til fremstilling af 20-alkyl-20-aminosteroider eller salte deraf.
CH1037763A CH427790A (fr) 1962-08-27 1963-08-22 Procédé de préparation de nouveaux aminostéroïdes
CH1037863A CH433283A (fr) 1962-08-27 1963-08-22 Procédé de préparation de nouveaux aminostéroïdes
CH532166A CH434251A (fr) 1962-08-27 1963-08-22 Procédé de préparation de nouveaux aminostéroïdes
ES290991A ES290991A1 (es) 1962-08-27 1963-08-22 Procedimiento de preparación de amino esteroides
CH1037963A CH421958A (fr) 1962-08-27 1963-08-22 Procédé de préparation de nouveaux aminostéroïdes
CH532066A CH429721A (fr) 1962-08-27 1963-08-22 Procédé de préparation de 3-oxo-20-méthyl-20-dialcoylamino 4-pregnènes
CH1037663A CH427789A (fr) 1962-08-27 1963-08-22 Procédé de préparation de nouveaux aminostéroïdes
GB3393563A GB1025905A (en) 1962-08-27 1963-08-27 New aminc-steroid compounds and processes for their preparation
FR976906A FR121F (fr) 1962-08-27 1964-06-03

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR907856A FR1421231A (fr) 1962-08-27 1962-08-27 Nouveaux amino-stéroïdes et procédé de préparation
FR916749A FR2374M (fr) 1962-08-27 1962-11-27 Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne ou vasculaire.

Publications (1)

Publication Number Publication Date
FR56F true FR56F (fr) 1964-10-16

Family

ID=8785774

Family Applications (3)

Application Number Title Priority Date Filing Date
FR907856A Expired FR1421231A (fr) 1962-08-27 1962-08-27 Nouveaux amino-stéroïdes et procédé de préparation
FR916749A Expired FR2374M (fr) 1962-08-27 1962-11-27 Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne ou vasculaire.
FR933624A Expired FR56F (fr) 1962-08-27 1963-05-03 Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne ou vasculaire.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
FR907856A Expired FR1421231A (fr) 1962-08-27 1962-08-27 Nouveaux amino-stéroïdes et procédé de préparation
FR916749A Expired FR2374M (fr) 1962-08-27 1962-11-27 Nouveau médicament notamment pour le traitement des spasmes d'origine coronarienne ou vasculaire.

Country Status (6)

Country Link
BE (1) BE636641A (fr)
DE (4) DE1212082B (fr)
ES (1) ES290991A1 (fr)
FR (3) FR1421231A (fr)
GB (4) GB1025906A (fr)
NL (4) NL297133A (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013008A (en) * 1961-01-09 1961-12-12 Searle & Co N-substituted 20-aminopregnan-3-ols, esters thereof, and deta-derivatives corresponding

Also Published As

Publication number Publication date
ES290991A1 (es) 1963-12-01
NL297133A (fr)
GB1025906A (en) 1966-04-14
BE636641A (fr)
DE1212081B (de) 1966-03-10
FR2374M (fr) 1964-04-03
NL297131A (fr)
FR1421231A (fr) 1965-12-17
GB1025907A (en) 1966-04-14
NL123751C (fr)
DE1212083B (de) 1966-03-10
DE1212082B (de) 1966-03-10
GB1025908A (en) 1966-04-14
GB1045644A (en) 1966-10-12
NL297135A (fr)
DE1212080B (de) 1966-03-10

Similar Documents

Publication Publication Date Title
FR1764M (fr) Nouveau médicament notamment pour le traitement des spasmes d&#39;origine coronarienne ou viscérale.
FR2969M (fr) Nouveau médicament notamment pour le traitement des spasmes d&#39;origine coronarienne on viscérale.
FR341M (fr) Nouveau médicament stéroide tétrahydroxylé notamment pour le traitement des spasmes d&#39;origine coronaire.
FR1438M (fr) Nouveau médicament efficace dans le traitement de l&#39;athérosclérose.
FR2374M (fr) Nouveau médicament notamment pour le traitement des spasmes d&#39;origine coronarienne ou vasculaire.
FR2053M (fr) Nouveau médicament notamment pour le traitement des spasmes d&#39;origine coronarienne ou vasculaire.
FR2810M (fr) Nouveau médicament notamment pour le traitement des spasmes d&#39;origine coronarienne ou viscérale.
FR1886M (fr) Nouveau médicament notamment pour le traitement des spasmes d&#39;origine coronarienne ou viscérale.
FR1946M (fr) Nouveau médicament notamment pour le traitement des spasmes d&#39;origine coronarienne.
FR2681M (fr) Nouveau médicament notamment pour le traitement des spasmes d&#39;origine coronarienne.
FR1598M (fr) Nouveau médicament notamment pour le traitement des spasmes d&#39;origine vasculaire, coronarienne ou viscérale.
FR2778M (fr) Nouveaux médicaments notamment pour le traitement des spasmes d&#39;origine coronarienne, vasculaire ou viscérale.
FR1141M (fr) Nouveau médicament notamment pour le traitement des spasmes d&#39;origine coronarienne.
FR1635M (fr) Nouveau médicament notamment pour le traitement des spasmes d&#39;origine coronarienne.
BE612141Q (fr) Nouveaux médicaments notamment pour le traitement des spasmes d&#39;origine coronaire.
FR2961M (fr) Nouveau médicament notamment pour le traitement des spasmes d&#39;origine coronarienne ou viscérale.
FR1418M (fr) Nouveau médicament pour le traitement des spasmes d&#39;origine coronarienne.
FR1508M (fr) Nouveau médicament notamment pour le traitment des spasmes d&#39;origine vasculaire.
BE616479A (fr) Agents de traitement des spasmes d&#39;origine vasculaire
FR2338M (fr) Nouveaux remedes destinés notamment au traitement des céphalées d&#39;origine vasculaire.
FR2974M (fr) Nouveau médicament notamment pour le traitement des spasmes d&#39;origine coronarienne et des troubles circulatoires.
FR1407M (fr) Nouveau médicament notamment pour le traitement des spasmes d&#39;origine vasculaire.
FR133M (fr) Nouveau médicament dihydroxylé notamment pour le traitement des spasmes d&#39;origine coronaire.
FR129M (fr) Nouveau médicament acétoxylé pour le traitement des spasmes d&#39;origine coronaire.
FR151M (fr) Nouveau médicament notamment pour le traitement des états neuro-dépressifs et des psychoses d&#39;anxiété.